Condition: Alzheimer Disease · Sponsor: REGEnLIFE SAS
This is a controlled investigation, with randomization of the patients, which aims at demonstrating the efficacy of device RGn600 in treating patients with mild-to-moderate Alzheimer's disease (AD). RGn600 is a non-invasive medical device which is applied on the head (helmet) and on the abdomen (abdominal belt). It combines 2 technologies: * PhotoBioModulation (PBM), which involves exposure to light from the red to near-infrared wavelengths using lasers and Light Emitting Diodes (LEDs) * Static Magnetic Stimulation (SMS), which consists in the application of a static magnetic field. Considering previous investigations, this innovative technology could reduce inflammation on the brain-gut axis, implicated in the development of Alzheimer's disease.
This description comes directly from the study's public registry record.
Guillaume CHAMPLEBOUX · +33 649 813 454 · gchampleboux@regenlife.com
Always discuss trial participation with your own doctor first.
| CHIC Castres Mazamet Site Autan | Castres, France | Recruiting |
| CH Lavaur | Lavaur, France | Recruiting |
| Hôpital Lariboisière | Paris, France | Not Yet Recruiting |
| Hôpital Broca | Paris, France | Not Yet Recruiting |
| Hôpital de la Timone, | Timone, France | Not Yet Recruiting |
| Toulouse University Hospital Gerontopole | Toulouse, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05926011